Home > Balance Sheet > MARKSANS PHARMA

MARKSANS PHARMA
Net Current Assets

    Back to Balance Sheet
MARKSANS PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for MARKSANS PHARMA
Please provide your vote to see the results

MARKSANS PHARMA Last 5 Year Net Current Assets History

[Consolidated]

Mar2023Mar2022Mar2021Mar2020Mar2019
Net Current Assets (Including Current Investments) ₹1,334 Cr₹845 Cr₹604 Cr₹365 Cr₹299 Cr

What is the latest Net Current Assets ratio of MARKSANS PHARMA ?

The latest Net Current Assets ratio of MARKSANS PHARMA is ₹1,334 Cr based on Mar2023 Consolidated results.
Year Net Current Assets
Mar2023₹1,334 Cr
Mar2022₹845 Cr
Mar2021₹604 Cr
Mar2020₹365 Cr
Mar2019₹299 Cr

How is Net Current Assets of MARKSANS PHARMA Trending?

Years Net Current Assets % Change
Mar2023 ₹1,334 Cr
57.91
Mar2022 ₹845 Cr
39.93
Mar2021 ₹604 Cr
65.51
Mar2020 ₹365 Cr
22.09
Mar2019 ₹299 Cr -

Compare Net Current Assets of peers of MARKSANS PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MARKSANS PHARMA ₹7,634.2 Cr 1% 0.4% 137.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹356,673.0 Cr -2.9% 0% 59.6% Stock Analytics
CIPLA ₹119,930.0 Cr 5.8% 6.2% 60.9% Stock Analytics
DIVIS LABORATORIES ₹109,446.0 Cr 5% 8% 25.9% Stock Analytics
ZYDUS LIFESCIENCES ₹108,261.0 Cr -2.6% 15.3% 114.4% Stock Analytics
DR REDDYS LABORATORIES ₹97,830.6 Cr 0.9% -1.5% 32.2% Stock Analytics


MARKSANS PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MARKSANS PHARMA

1%

0.4%

137.6%

SENSEX

2%

2.3%

22.2%


You may also like the below Video Courses